Changes to the REHQR Program Measure Set In the CY 2026 OPPS/ASC proposed rule (90 FR 33768 through 337722), we proposed to adopt the Emergency Care Access & Timeliness electronic clinical quality measure (eCQM) beginning with the CY 2027 reporting period/CY 2029 program determination as an alternative to reporting the Median Time from Emergency Department (ED) Arrival to ED Departure for Discharged ED Patients measure
The panel determined the type of dementia and the date of diagnosis using serial neurological and neuropsychological assessments, a telephone interview with a family member or a caregiver, medical records, and imaging study results
Why NAD+ declines with age Natural age-related decline : Decreased production Increased consumption (more cellular stress) Reduced recycling efficiency Mitochondrial dysfunction By age 50 : NAD+ levels about half of age 20 levels Impact : Everything from energy to recovery to longevity affected NAD+ boosting strategies Oral supplements (NMN, NR): Precursors that convert to NAD+ Variable absorption (5-30%) Modest NAD+ increase Affordable ($30-60/month) NAD+ IV therapy : Direct NAD+ infusion Immediate high levels Very expensive ($300-800 per session) Requires clinic visits NAD+ peptides : Stimulate natural NAD+ production Excellent bioavailability Sustained elevation Cost-effective ($50-150/month) Self-administered Best results : NAD+ peptides offer superior bioavailability and sustained effects vs oral supplements, at fraction of IV cost
Sch Psychol Int 31:478494 Saad K, Abdel-rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjrklund G, Abdel-Reheim MK, Othman HA et al (2016) Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children
